ENLIVEN THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $7.6M | $93.6M | $48.3M |
| FY2022 | $10.4M | $83.3M | $75.5M |
| FY2023 | $26.0M | $271.9M | $100.1M |
| FY2024 | $15.9M | $325.8M | $124.1M |
| FY2025 | $16.6M | $476.2M | $98.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $7.6M | $93.6M | $48.3M |
| FY2022 | $10.4M | $83.3M | $75.5M |
| FY2023 | $26.0M | $271.9M | $100.1M |
| FY2024 | $15.9M | $325.8M | $124.1M |
| FY2025 | $16.6M | $476.2M | $98.9M |